Brian M Calimlim

10PUBLICATIONS
51CO-AUTHORS
Environmental epidemiologyGene and molecular therapyAllergyEpidemiological methodsMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 02, 2025
Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic Dermatitis.

Eric L Simpson, Jonathan I Silverberg, Vimal H Prajapati

|May 02, 2024
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2).

Eric L Simpson, Vimal H Prajapati, Yael A Leshem

|Mar 26, 2024
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2).

Jonathan I Silverberg, Melinda J Gooderham, Amy S Paller

|Dec 18, 2023
Aggregate Response Benefit in Skin Clearance and Itch Reduction With Upadacitinib or Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis®.

Jonathan I Silverberg, Marjolein de Bruin-Weller, Brian M Calimlim

|Sep 05, 2023
Real-world clinical, psychosocial and economic burden of atopic dermatitis: Results from a multicountry study.

Kilian Eyerich, Melinda J Gooderham, Juan Francisco Silvestre

|Aug 01, 2023
Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: Results from a phase 2b, randomized, controlled trial.

Emma Guttman-Yassky, Jonathan I Silverberg, Diamant Thaçi

Pageof 2

Frequent Collaborators

7 joint publications

Jonathan I Silverberg

3 joint publications

Andrew M Platt

3 joint publications

Jacob P Thyssen

3 joint publications

Wan-Ju Lee